| Analysis of 13 cell types reveals evidence for the expression of numerous novel primate-and tissue-specific microRNAs E Londin, P Loher, AG Telonis, K Quann, P Clark, Y Jing, E Hatzimichael, ... Proceedings of the National Academy of Sciences 112 (10), E1106-E1115, 2015 | 409 | 2015 |
| MEG3 imprinted gene contribution in tumorigenesis L Benetatos, G Vartholomatos, E Hatzimichael International journal of cancer 129 (4), 773-779, 2011 | 280 | 2011 |
| The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis L Benetatos, E Hatzimichael, E Londin, G Vartholomatos, P Loher, ... Cellular and molecular life sciences 70 (5), 795-814, 2013 | 234 | 2013 |
| CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes L Benetatos, E Hatzimichael, A Dasoula, G Dranitsaris, S Tsiara, M Syrrou, ... Leukemia research 34 (2), 148-153, 2010 | 157 | 2010 |
| The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman’s disease T Powles, J Stebbing, A Bazeos, E Hatzimichael, S Mandalia, M Nelson, ... Annals of oncology 20 (4), 775-779, 2009 | 151 | 2009 |
| The role of cytokines in sickle cell disease AC Makis, EC Hatzimichael, KL Bourantas Annals of hematology 79 (8), 407-413, 2000 | 132 | 2000 |
| Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents MA Dimopoulos, S Delimpasi, E Katodritou, A Vassou, MC Kyrtsonis, ... Annals of oncology 25 (1), 195-200, 2014 | 123 | 2014 |
| Hematopoietic stem cell transplantation E Hatzimichael, M Tuthill Stem cells and cloning: advances and applications 3, 105, 2010 | 117 | 2010 |
| Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma N Syed, J Langer, K Janczar, P Singh, CL Nigro, L Lattanzio, HM Coley, ... Cell death & disease 4 (1), e458-e458, 2013 | 111 | 2013 |
| Serum interleukin (IL)‐1, IL‐2, sIL‐2Ra, IL‐6 and thrombopoietin levels in patients with chronic myeloproliferative diseases KE Panteli, EC Hatzimichael, PK Bouranta, A Katsaraki, K Seferiadis, ... British journal of haematology 130 (5), 709-715, 2005 | 110 | 2005 |
| Cancer epigenetics: new therapies and new challenges E Hatzimichael, T Crook Journal of drug delivery 2013, 2013 | 95 | 2013 |
| Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis B Delage, P Luong, L Maharaj, C O’riain, N Syed, T Crook, ... Cell death & disease 3 (7), e342-e342, 2012 | 95 | 2012 |
| Promoter hypermethylation of the MEG3 (DLK1/MEG3) imprinted gene in multiple myeloma L Benetatos, A Dasoula, E Hatzimichael, I Georgiou, M Syrrou, ... Clinical Lymphoma and Myeloma 8 (3), 171-175, 2008 | 87 | 2008 |
| Revisiting bleomycin from pathophysiology to safe clinical use M Froudarakis, E Hatzimichael, L Kyriazopoulou, K Lagos, P Pappas, ... Critical reviews in oncology/hematology 87 (1), 90-100, 2013 | 84 | 2013 |
| Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients C Sfagos, AC Makis, A Chaidos, EC Hatzimichael, A Dalamaga, K Kosma, ... Multiple Sclerosis Journal 11 (3), 272-275, 2005 | 82 | 2005 |
| Non‐coding RNAs and EZH2 interactions in cancer: long and short tales from the transcriptome L Benetatos, E Voulgaris, G Vartholomatos, E Hatzimichael International journal of cancer 133 (2), 267-274, 2013 | 77 | 2013 |
| NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity H Wang, S Lee, CL Nigro, L Lattanzio, M Merlano, M Monteverde, R Matin, ... British Journal of Cancer 106 (8), 1446-1452, 2012 | 77 | 2012 |
| Gene mutations and molecularly targeted therapies in acute myeloid leukemia E Hatzimichael, G Georgiou, L Benetatos, E Briasoulis American journal of blood research 3 (1), 29, 2013 | 72 | 2013 |
| The human platelet: strong transcriptome correlations among individuals associate weakly with the platelet proteome ER Londin, E Hatzimichael, P Loher, L Edelstein, C Shaw, K Delgrosso, ... Biology direct 9 (1), 1-12, 2014 | 68 | 2014 |
| Clinical trial design in biosimilar drug development G Dranitsaris, K Dorward, E Hatzimichael, E Amir Investigational new drugs 31 (2), 479-487, 2013 | 56 | 2013 |
